The Role of Gut Microbiota Dysbiosis in the Pathogenesis and Management of Diabetes Mellitus

References

[1] Abdalqadir, N., & Adeli, K. (2022). GLP1 and GLP2 orchestrate intestinal integrity, gut microbiota, and immune system crosstalk. Microorganisms, 10(10), 2061. https://doi.org/10.3390/microorganisms10102061

[2] Bitew, Z. W., Alemu, A., Jember, D. A., Tadesse, E., Getaneh, F. B., Sied, A., & Weldeyonnes, M. (2023, January 1). Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis. Inquiry (United States). SAGE Publications Inc. https://doi.org/10.1177/00469580231155716

[3] Dedefo, M. G., Abate, S. K., Ejeta, B. M., & Korsa, A. T. (2020). Predictors of poor glycemic control and level of glycemic control among diabetic patients in West Ethiopia. Annals of Medicine and Surgery, 55, 238–243. https://doi.org/10.1016/j.amsu.2020.04.034

[4] Dedefo, M. G., Abate, S. K., Ejeta, B. M., & Korsa, A. T. (2020). Predictors of poor glycemic control and level of glycemic control among diabetic patients in West Ethiopia. Annals of Medicine and Surgery, 55, 238–243. https://doi.org/10.1016/j.amsu.2020.04.034

[5] Degruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016). Current understanding of dysbiosis in disease in human and animal models. Inflammatory Bowel Diseases, 22(5), 1137–1150. https://doi.org/10.1097/MIB.0000000000000750

[6] Ejtahed, H. S., et al. (2012). Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition Research, 32(7), 493–498. https://doi.org/10.1016/j.nutres.2012.03.009

[7] Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., … Martín, C. (2020, September 1). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21176275

[8] Ghukasyan, L. R. (2020). Diabetes mellitus and periodontal disease. Bulletin of Stomatology and Maxillofacial Surgery, 17(3), 17–20. https://doi.org/10.52403/ijrr.202308107

[9] Han, Z. Y., Chen, Q. W., Fu, Z. J., Cheng, S. X., & Zhang, X. Z. (2022). Probiotic Spore-Based Oral Drug Delivery System for Enhancing Pancreatic Cancer Chemotherapy by Gut-Pancreas-Axis-Guided Delivery. Nano Letters, 22(21), 8608–8617. https://doi.org/10.1021/acs.nanolett.2c03131

[10] Han, Z. Y., Chen, Q. W., Fu, Z. J., Cheng, S. X., & Zhang, X. Z. (2022). Probiotic Spore-Based Oral Drug Delivery System for Enhancing Pancreatic Cancer Chemotherapy by Gut-Pancreas-Axis-Guided Delivery. Nano Letters, 22(21), 8608–8617. https://doi.org/10.1021/acs.nanolett.2c03131

[11] Hooks, K. B., & O’Malley, M. A. (2017). Dysbiosis and its discontents. MBio, 8(5). https://doi.org/10.1128/mBio.01492-17

[12] Karlsson, F. H., et al. (2013). Gut metagenome in European women with normal, impaired, and diabetic glucose control. Nature, 498(7452), 99–103. https://doi.org/10.1038/nature12506

[13] Khadilkar, A., & Oza, C. (2022). Glycaemic Control in Youth and Young Adults: Challenges and Solutions. Diabetes, Metabolic Syndrome and Obesity. Dove Medical Press Ltd. https://doi.org/10.2147/DMSO.S304347

[14] Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., … et al. (2013). The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nature Communications, 4, 1829. https://doi.org/10.1038/ncomms2852

[15] Koh, A., De Vadder, F., KovatchevaDatchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332–1345. https://doi.org/10.1016/j.cell.2016.05.041

[16] Kostic, A. D., et al. (2015). The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell, 165(2), 385–400. https://doi.org/10.1016/j.cell.2015.03.008

[17] Kurniawaty, E. (2020). Diabetes Mellitus Diabetes Mellitus. Ferri’s Clinical Advisor 2020, 512(58), 432–441.

[18] Liu, B. N., Liu, X. T., Liang, Z. H., & Wang, J. H. (2021, July 7). Gut microbiota in obesity. World Journal of Gastroenterology. Baishideng Publishing Group Inc. https://doi.org/10.3748/wjg.v27.i25.3837

[19] Qin, J., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 490(7418), 55–60. https://doi.org/10.1038/nature11450

[20] Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020, January 31). The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology. Frontiers Media S.A. https://doi.org/10.3389/fendo.2020.00025

[21] Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020, August 2). Gut-pancreas-liver axis as a target for treatment of NASH/nash. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21165820

[22] Wachsmuth, H. R., Weninger, S. N., & Duca, F. A. (2022). Role of the gut–brain axis in energy and glucose metabolism. Experimental & Molecular Medicine, 54, 377–392. https://doi.org/10.1038/s12276-021-00677-w

[23] Wu, H., et al. (2017). Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes. Nature Medicine, 23(7), 850–858. https://doi.org/10.1038/nature15766

[24] Yamashiro, Y. (2018, January 1). Gut Microbiota in Health and Disease. Annals of Nutrition and Metabolism. S. Karger AG. https://doi.org/10.1159/000481627

[25] Zeevi, D., et al. (2015). Personalized nutrition by prediction of glycemic responses. Cell, 163(5), 1079–1094. https://doi.org/10.1016/j.cell.2015.11.001

@article{1709672,
      author = {Tamanna Akter, Bibi Ayesa, Mst Shahinur Begum; Farheen Iqbal, Banasree Roy Urmi; Aditta Das, Sayed Hossain; Md. Jobaer Rahman Rashed},
      title = {The Role of Gut Microbiota Dysbiosis in the Pathogenesis and Management of Diabetes Mellitus},
      journal = {Iconic Research And Engineering Journals},
      year = {2024},
      volume = {7},
      number = {10},
      pages = {568-576},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1709672.pdf},
      abstract = {It has been found that diabetes mellitus a worldwide metabolic dilemma characterized by persistent hyperglycemia is progressively linked to changes in the intestinal microbiome. The gut microbiota, a complex ecosystem of microorganisms found in the gastrointestinal tract, plays a crucial role in maintaining metabolic homeostasis. New evidence has also emphasized the role and importance of the gut-pancreatic axis in regulating glucose homeostasis with dysbiosis leaving the ability to secrete and act on insulin compromised due to inflammatory mechanisms, aberration of incretin response, and changes in short-chain fatty acid production. This review summarizes the existing data associating the gut microbiota disproportion with the pathophysiology of diabetes mellitus (DM) and discusses the potential of restoring a microbiota balance using therapeutic options. Probiotics, prebiotics, diet, and fecal microbiota transplantation have demonstrated the potential to affect glycemic control by improving insulin sensitivity and affecting host metabolism. Along with these encouraging results, it is necessary to conduct additional studies to understand the causal links and lay a foundation for understanding personalized, microbiota-directed treatment. This literature review underlines the topicality of manipulation of gut microbiota in diabetes management and proposes further directions for microbiome-guided interventions.},
      keywords = {Gut microbiota, Gut?pancreas axis, Glycemic control, Diabetes mellitus, Dysbiosis},
      month = {April},
  }